Sivelestat (INN, research name ONO 5046, marketed as Elaspol) is an inhibitor of human neutrophil elastase.

[1] It is used in the treatment of acute respiratory failure[2] and preliminary studies show it may also improve neuropathic pain.

[3] Sivelestat is synthesised as follows:[4]

This drug article relating to the respiratory system is a stub.

You can help Wikipedia by expanding it.